Company
Mesosil
Sustained Release Antimicrobial Additives
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Founded
- 2018
Record updated 18 September 2026
About
Mesosil’s innovative silica-based platform enables high-capacity delivery and sustained release of bioactive agents, addressing critical challenges in infection prevention and biomaterial longevity. In dental materials, our technology reduces recurrent tooth decay by up to 80%. With applications in orthopedics, implantable devices, and other medical fields currently under evaluation, Mesosil is creating the next generation of long-term antimicrobial protection. Our platform seamlessly integrates into existing manufacturing and clinical workflows, offering a scalable, high-impact solution for the future of medical materials.
Products
- Other
- Mesosil 500